Patent Licensing Details

Technology reference number: 201611021901
First Published on:
Title of the technology: Isolated Single stranded DNA and uses thereof in diagnosis and treatment of Tuberculous Meningitis
Technology Brief: Unique non-naturally occurring isolated single stranded DNA aptamers against GlcB antigen.
Potential Application(s): TBM diagnosis and Treatment
Advantage(s): High specificity | High affinity | Highly stable binding complex
IP status: Provisional Patent Application filed
Development status: Proof of concept established
Researcher(s):
Owner(s): THSTI | AIIMS
Last date to receive interest: 26/08/2016
Image(s):

Click on image for full view